Video

Facing Advanced Cancer's Struggles With CALM

Gary Rodin, M.D., head of the Department of Supportive Care at Princess Margaret Cancer Centre, in Toronto, Canada, discusses CALM, an intervention designed to help patients with advanced-stage cancer cope and talk about their concerns.

Gary Rodin, M.D., head of the Department of Supportive Care at Princess Margaret Cancer Centre, in Toronto, Canada, discusses CALM, an intervention designed to help patients with advanced-stage cancer cope and talk about their concerns.

Patients with advanced or metastatic cancer often face a great deal of distress, as they and their families must make decisions regarding treatments and end of life care. CALM was designed to help these patients, by giving them an outlet to discuss four main points: symptom control, self-concept and personal relationships, meaning in life and fears and concerns regarding the future. Having an outlet for these thoughts is beneficial, especially in the world of oncology, where appointments may be very short or focused more on the next treatment steps.

In a trial involving 300 patients, half were assigned CALM, which is run by trained health care professionals in three to six sessions, and the other half received standard of care. Those who were involved in CALM demonstrated fewer depressive symptoms. Now, Rodin and his team are training health care professions in more than 20 countries to use CALM and help patients around the globe.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man with text.
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.
Terry Gillespie said the hardest parts of her cancer journey were the isolation, the impact of chemotherapy, and how unprepared she felt despite good guidance.
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Outpatient CAR T-cell therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Related Content